Histopathological Plus Limited 12902161 false 2023-10-01 2024-09-30 2024-09-30 The principal activity of the company is Histopathology Digita Accounts Production Advanced 6.30.9574.0 true 12902161 2023-10-01 2024-09-30 12902161 2024-09-30 12902161 bus:Director1 1 2024-09-30 12902161 core:CurrentFinancialInstruments core:WithinOneYear 2024-09-30 12902161 bus:Micro-entities 2023-10-01 2024-09-30 12902161 bus:AuditExemptWithAccountantsReport 2023-10-01 2024-09-30 12902161 bus:FilletedAccounts 2023-10-01 2024-09-30 12902161 bus:SmallCompaniesRegimeForAccounts 2023-10-01 2024-09-30 12902161 bus:RegisteredOffice 2023-10-01 2024-09-30 12902161 bus:Director1 2023-10-01 2024-09-30 12902161 bus:Director1 1 2023-10-01 2024-09-30 12902161 bus:PrivateLimitedCompanyLtd 2023-10-01 2024-09-30 12902161 bus:Agent1 2023-10-01 2024-09-30 12902161 countries:EnglandWales 2023-10-01 2024-09-30 12902161 bus:Director1 1 2023-09-30 12902161 2023-01-01 2023-09-30 12902161 2023-09-30 12902161 core:CurrentFinancialInstruments core:WithinOneYear 2023-09-30 iso4217:GBP xbrli:pure

Registration number: 12902161

Histopathological Plus Limited

Unaudited Filleted Financial Statements

for the Year Ended 30 September 2024

 

Histopathological Plus Limited

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Unaudited Financial Statements

2

 

Histopathological Plus Limited

Company Information

Director

Dr S Neda

Registered office

31 Cairns Court
Norwich
NR4 7PT

Accountants

Cannon and Company Accountants Limited
Chartered Certified AccountantsUnit 1A
Park Farm Road
Folkestone
Kent
CT19 5EY

 

Histopathological Plus Limited

(Registration number: 12902161)
Balance Sheet as at 30 September 2024

2024
£

2023
£

Fixed assets

1,019

-

Current assets

183,096

106,272

Prepayments and accrued income

-

(1)

Creditors: Amounts falling due within one year

(22,095)

(13,992)

Net current assets

161,001

92,279

Total assets less current liabilities

162,020

92,279

Accruals and deferred income

(490)

(432)

 

161,530

91,847

Capital and reserves

161,530

91,847

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
31 Cairns Court
Norwich
NR4 7PT
England

These financial statements were authorised for issue by the director on 24 June 2025.

2

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2023 - 1).

3

Related party transactions

Transactions with the director

2024

At 1 October 2023
£

Advances to director
£

Repayments by director
£

At 30 September 2024
£

Dr S Neda

-

(75)

2,155

2,080

For the financial year ending 30 September 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

 

Histopathological Plus Limited

(Registration number: 12902161)
Balance Sheet as at 30 September 2024

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the micro entities regime and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 24 June 2025
 

.........................................
Dr S Neda
Director